Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Grete Semb

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Nature Reviews. Rheumatology|April 25, 2018
Optimization of CVD prevention in psoriatic arthritisAnne Grete Semb, Silvia Rollefstad
Nature Reviews. Rheumatology|July 1, 2016
Spondyloarthropathies: CVD prevention and statin therapy in ankylosing spondylitisAnne Grete Semb, Silvia Rollefstad
European Heart Journal. Cardiovascular Pharmacotherapy|June 26, 2026
Why Cardio-Rheumatology?Anne Grete Semb, Eirik Ikdahl, Anne Kerola
European Cardiology|May 27, 2021
Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic TreatmentAnne Mirjam Kerola, Silvia Rollefstad, Anne Grete Semb
Annals of the Rheumatic Diseases|April 23, 2024
No sign of elevated cardiovascular risk in patients with seropositive rheumatoid arthritis who remain on stable antirheumatic therapy: results from the nationwide Norwegian Cardio-Rheuma RegisterEirik Ikdahl, Anne Grete Semb, Anne M Kerola
European Heart Journal. Cardiovascular Pharmacotherapy|August 15, 2024
All about clinical trialsAnne Grete Semb, Julie Sanders, Juan Carlos Kaski
BMJ Case Reports|June 22, 2011
Effect of high-intensity statin treatment in rheumatoid arthritis: a case with possible coronary atheroma regression and progression of rheumatoid valve degenerationAnne Grete Semb, Sella Provan, Tore Kvien, et al.
European Cardiology|January 28, 2025
Cardiovascular Implications of Non-steroidal Anti-inflammatory Drugs: A Comprehensive Review, with Emphasis on Patients with Rheumatoid ArthritisEirik Ikdahl, Anne Kerola, Eli Sollerud, et al.
Rheumatology (Oxford, England)|February 10, 2016
Chronic kidney disease reduces risk of cardiovascular disease in patients with rheumatoid arthritis according to the QRISK lifetime cardiovascular risk calculatorEirik Ikdahl, Silvia Rollefstad, Grunde Wibetoe, et al.
Rheumatology (Oxford, England)|June 8, 2014
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatmentErnest Choy, Kandeepan Ganeshalingam, Anne Grete Semb, et al.
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Nature Reviews. Rheumatology|April 25, 2018
Optimization of CVD prevention in psoriatic arthritisAnne Grete Semb, Silvia Rollefstad
Nature Reviews. Rheumatology|July 1, 2016
Spondyloarthropathies: CVD prevention and statin therapy in ankylosing spondylitisAnne Grete Semb, Silvia Rollefstad
European Heart Journal. Cardiovascular Pharmacotherapy|June 26, 2026
Why Cardio-Rheumatology?Anne Grete Semb, Eirik Ikdahl, Anne Kerola
European Cardiology|May 27, 2021
Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic TreatmentAnne Mirjam Kerola, Silvia Rollefstad, Anne Grete Semb
Annals of the Rheumatic Diseases|April 23, 2024
No sign of elevated cardiovascular risk in patients with seropositive rheumatoid arthritis who remain on stable antirheumatic therapy: results from the nationwide Norwegian Cardio-Rheuma RegisterEirik Ikdahl, Anne Grete Semb, Anne M Kerola
European Heart Journal. Cardiovascular Pharmacotherapy|August 15, 2024
All about clinical trialsAnne Grete Semb, Julie Sanders, Juan Carlos Kaski
BMJ Case Reports|June 22, 2011
Effect of high-intensity statin treatment in rheumatoid arthritis: a case with possible coronary atheroma regression and progression of rheumatoid valve degenerationAnne Grete Semb, Sella Provan, Tore Kvien, et al.
European Cardiology|January 28, 2025
Cardiovascular Implications of Non-steroidal Anti-inflammatory Drugs: A Comprehensive Review, with Emphasis on Patients with Rheumatoid ArthritisEirik Ikdahl, Anne Kerola, Eli Sollerud, et al.
Rheumatology (Oxford, England)|February 10, 2016
Chronic kidney disease reduces risk of cardiovascular disease in patients with rheumatoid arthritis according to the QRISK lifetime cardiovascular risk calculatorEirik Ikdahl, Silvia Rollefstad, Grunde Wibetoe, et al.
Rheumatology (Oxford, England)|June 8, 2014
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatmentErnest Choy, Kandeepan Ganeshalingam, Anne Grete Semb, et al.
Pageof 12